In CML, an increase in heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) leads to an enhanced mRNA stability, which produces an increase in SET protein levels (9). Here, SET is linked to chronic myelogenous leukemia, BCR-ABL1 positive.